The Influence Foundation
This page was last edited on at
Background
The Influence Foundation was founded in New York in 2017. Its stated aim is “to advocate through journalism for rational and compassionate approaches to drug use, drug policy and human rights”.1 It is part-funded by tobacco companies and related third parties.
The Influence Foundation owns and operates Filter magazine, which has published multiple articles criticising tobacco control policies23, and arguing against regulations relating to newer nicotine and tobacco products.45
Links to the Tobacco Industry
Direct funding from tobacco companies
The Influence Foundation receives funding from tobacco companies including Philip Morris International (PMI), Altria, and British American Tobacco (BAT) subsidiary Reynolds American Inc, as well as from the e-cigarette company JUUL Labs, which was part-owned by Altria between 2018 and 2023.6
Supported by the Foundation for a Smoke-Free World / Global Action to End Smoking
It is also a grantee of the Foundation for a Smoke-Free World (FSFW), an organisation wholly funded by PMI under a multi-year pledge (2018-23). In May 2024 FSFW rebranded as Global Action to End Smoking (GAES), which continues to operate on the remaining PMI funds.789
In 2020, FSFW awarded a grant of US$90,000 to Law Enforcement Action Partnership (LEAP), the Influence Foundation’s past fiscal sponsor, to “Build capacity to share stories that present facts about tobacco harm reduction and nicotine use to all stakeholders” through Filter magazine.10 LEAP also accepts funding from tobacco companies.1112
In 2021, the Influence Foundation received a grant of US$167,709 from FSFW to “Expand Filter’s capacity to produce, publish, and promote informative and evidence-based THR [tobacco harm reduction] information and articles with higher volume, quality, and reach.”1314 In 2022, it received US$71,877 for the same Filter capacity expansion project, and another grant of US$237,640 to “Support the capacity of Filter Magazine to communicate about tobacco harm reduction)”.1516
In 2023, FSFW/GAES paid the Influence Foundation US$169,744 to support Filter Magazine’s capacity.9 In July and August that year, Filter magazine published articles ahead of the 10th Conference of the Parties (COP 10) to the World Health Organization Framework Convention on Tobacco Control (WHO FCTC). Written by the pro-tobacco blogger and International Fellow at the Taxpayers’ Protection Alliance (TPA), Martin Cullip, they criticised the WHO and its supposed “assault on tobacco harm reduction”.1718 Around the COP 10 meeting in early 2024, Filter published further articles by Lindsey Stroud of the TPA.192021 The TPA provided funding to the Influence Foundation “to support travel to Good COP”, a parallel meeting run by the TPA during COP 10.22 For more information see Interference around COP 10 & MOP 3.
After FSFW rebranded to GAES in 2024, funding to the Influence Foundation continued, with US$127,308 awarded to “Support communication about tobacco harm reduction through Filter Magazine.”23 In the lead‑up to and during COP11, Filter published articles that criticised the WHO and framed its approach to tobacco harm reduction as hostile.2425 For more information see Interference around COP 11 & MOP 4.
The Influence Foundation has also received funding from industry third parties, including Knowledge-Action-Change (funded by FSFW/GAES) and R-Street Institute (part-funded by Altria).6
Board Members
Board members include:
- Will Godfrey, President and Executive Director of the Influence Foundation, and editor-in-chief of Filter.1 He is a regular attendee and speaker at the Global Forum on Nicotine,26 an annual conference organised by Knowledge-Action-Change, which each year features tobacco industry speakers and panellists.
- Diane Goldstein, the executive director of the Law Enforcement Action Partnership (LEAP), which has received funding from tobacco companies. Goldstein has presented at the UK Houses of Parliament and to Californian legislatures.1112
- Sheila Vakharia, the policy manager for the Office of Academic Engagement at the Drug Policy Alliance.27